Ricardo Attar
24Patents
7h-index
84Co-inventors
72Inventor score
Filing activity: Feb 23, 2000 → Jan 20, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8221765B2 | Multivalent fibronectin based scaffold domain proteins | Chemistry; Metallurgy | 63 | Active |
| US6960474B2 | Method for the treatment of a condition remediable by administration of a selective androgen receptor modulator | Human Necessities | 61 | Expired |
| US8728483B2 | Multivalent fibronectin based scaffold domain proteins | Chemistry; Metallurgy | 36 | Active |
| US9902762B2 | Multivalent fibronectin based scaffold domain proteins | Chemistry; Metallurgy | 27 | Active |
| US10072088B2 | Anti-BCMA antibodies and uses thereof | Chemistry; Metallurgy | 12 | Active |
| US9850310B2 | CD123 binding agents and uses thereof | Chemistry; Metallurgy | 12 | Active |
| US9695228B2 | EGFR and c-Met fibronectin type III domain binding molecules | Chemistry; Metallurgy | 10 | Active |
| US8492328B2 | Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators | Chemistry; Metallurgy | 4 | Active |
| US10562968B2 | Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US10774130B2 | Method of treating cancer by administering multivalent fibronectin based scaffold domain proteins | Chemistry; Metallurgy | 4 | Active |
| US7655688B2 | Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function | Human Necessities | 3 | Active |
| US6795776B1 | Crystallographic structure of the androgen receptor ligand binding domain | Physics | 3 | Expired |
| US10106620B2 | Blocking CD38 using anti-CD38 F(ab′)2 to protect NK cells | Chemistry; Metallurgy | 2 | Active |
| US6479237B1 | Methods for detecting interaction among several proteins | Chemistry; Metallurgy | 2 | Expired |
| US10662235B2 | Cysteine engineered fibronectin type III domain binding molecules | Chemistry; Metallurgy | 2 | Active |
| US9725497B2 | EGFR and C-Met fibronectin type III domain binding molecules | Chemistry; Metallurgy | 2 | Active |
| US7199227B2 | Polynucleotides encoding human histone deacetylase HDAC9c | Human Necessities | 0 | Expired |
| US12077592B2 | GPRC5D chimeric antigen receptors and cells expressing the same | Chemistry; Metallurgy | 0 | Active |
| US11685777B2 | Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11884722B2 | Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12018289B2 | Vaccines based on mutant CALR and JAK2 and their uses | Chemistry; Metallurgy | 0 | Active |
| US7225083B2 | Crystallographic structure of the androgen receptor ligand binding domain | Physics | 0 | Expired |
| US10954284B2 | EGFR and c-Met fibronectin type III domain binding molecules | Chemistry; Metallurgy | 0 | Active |
| US12304939B2 | EGFR and C-met fibronectin type III domain binding molecules | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.